ong-term study with the staphylococcus vaccine Staphypan in treatment of patients with fibromyalgia and chronic fatigue syndrome
Active, not recruiting
- Conditions
- Fibromyalgia M79.0 + Chronic fatigue syndrome F48.0
- Registration Number
- EUCTR2004-001281-40-SE
- Lead Sponsor
- Gottfries Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 135
Inclusion Criteria
Patients who fulfil the criteria of fibromyalgia and chronic fatigue syndrome and who have responded to treatment with the staphylococcus vaccine Staphypan.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method